ISRCTN23853712已完成未知
evamisole treatment for children with steroid sensitive nephrotic syndrome: a multicentre double-blind placebo-controlled randomised trial
Academic Medical Centre (AMC) (Netherlands)0 个研究点目标入组 100 人开始时间: 2009年9月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
2018 results in https://www.ncbi.nlm.nih.gov/pubmed/29054532 (added 18/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Primary diagnosis: frequently relapsing idiopathic SSNS with or without steroid dependency
- •2. Aged less than or equal to 18 years (not less than two years), either sex
- •3. Written Informed Consent
排除标准
- •1. Previously treated with Levamisole
- •2. Unresponsive to cyclosporine or mycophenolate mofetil (MMF)
- •3. Nephrotic syndrome due to specific kidney diseases
- •4. Patients with neutropenia, convulsions and hepatic disease
- •5. Patients with prolongation of the QTc-time on the surface electrocardiogram (greater than 0.44 secconds)
- •6. Pregnancy, breast-feeding or planned pregnancy during the study
- •7. Participation in another trial
研究者
相似试验
进行中（未招募）
不适用
evamisole treatment for children with steroid sensitive nephrotic syndrome. A multi-centre, double-blind, placebo-controlled, randomised trial. - Levamisol TrialEUCTR2005-005745-18-BEEmma Children's Hospital-AMC100
招募中
3 期
A clinical trial to study the effects of levamisole in children with steroid sensitive nephrotic syndromeCTRI/2009/091/000116Emma Childrens Hospital AMC100
招募中
不适用
evamisole treatment for children with steroid sensitive nephrotic syndrome.steroid sensitive idiopathic nephrotic syndrome(steroid gevoelig idiopathisch nefrotisch syndroom), relapse (recidief), levamisole, steroid side effects (steroid bijwerkingen),NL-OMON26305Academic Medical Center of AmsterdamMeibergdreef 9, 1105 AZ Amsterdam Z-OThe Netherlands100
已完成
3 期
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant PatientsRenal TransplantationNCT00170833Novartis Pharmaceuticals80
已完成
4 期
Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free RegimenRenal TransplantationNCT00170820Novartis Pharmaceuticals20